Lahiguera, Á., Hyrossová, P., Figueras i Amat, A., Garzón, D., Moreno, R., Soto Cerrato, V., . . . Viñals Canals, F. (2020). Tumors defective in homologous recombination rely on oxidative metabolism: Relevance to treatments with PARP inhibitors.
Citação norma ChicagoLahiguera, Álvaro, et al. Tumors Defective in Homologous Recombination Rely On Oxidative Metabolism: Relevance to Treatments With PARP Inhibitors. 2020.
Citação norma MLALahiguera, Álvaro, et al. Tumors Defective in Homologous Recombination Rely On Oxidative Metabolism: Relevance to Treatments With PARP Inhibitors. 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.